General Information of the Compound
| Compound ID |
CP0526017
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
8-(3-Nitro-phenyl)-6-pyridin-4-ylmethyl-quinoline
Show/Hide
|
||||||||||||||||||
| Synonyms |
159925-31-2
3g45
3g58
4CA-1115
8-(3-Nitro-phenyl)-6-pyridin-4-ylmethyl-quinoline
8-(3-nitrophenyl)-6-(4-pyridinylmethyl)Quinoline
8-(3-nitrophenyl)-6-(pyridin-4-ylmethyl)quinoline
AJ-08271
AKOS022171718
AX8257760
BDBM50092632
CHEMBL127944
DA-09714
DTXSID20431317
FT-0733089
KB-74213
RS-14203
SCHEMBL3698956
XRSKAWJXBDACRF-UHFFFAOYSA-N
ZINC6165
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C21H15N3O2
|
||||||||||||||||||
| Molecular Weight |
341.37
|
||||||||||||||||||
| Canonical SMILES |
[O-][N+](=O)c1cccc(c1)-c1cc(Cc2ccncc2)cc2cccnc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C21H15N3O2/c25-24(26)19-5-1-3-17(14-19)20-13-16(11-15-6-9-22-10-7-15)12-18-4-2-8-23-21(18)20/h1-10,12-14H,11H2
Show/Hide
|
||||||||||||||||||
| InChIKey |
XRSKAWJXBDACRF-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound